Walden, the leader in pharmaceutical logistics in Europe acquires the Belgian pharmaceutical transport company Ivemar PARIS, Nov. 9, 2023 /PRNewswire/ — The group integrates the Belgian company to support the development of its subsidiary Transpharma International, which specialises in first-mile pharmaceutical transport and global freight forwarding. « The acquisition of Ivemar provides Transpharma International with transport assets,… Continue reading Walden continues to invest in Belgium
Category: Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Holley Inc. f/k/a Empower Ltd. (“Holley” or the “Company”) (NYSE: HLLY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Holley and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DermTech, Inc. (“DermTech” or the “Company”) (NASDAQ: DMTK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DermTech and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DermTech, Inc. – DMTK
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Barclays PLC – BCS
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Barclays and certain of its officers and/or directors have engaged in securities fraud or other unlawful business… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Barclays PLC – BCS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DISH Network Corporation (“DISH” or the “Company”) (NASDAQ: DISH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether DISH and certain of its officers and/or directors have engaged in securities fraud… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DISH Network Corporation – DISH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRN
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capstone Green Energy Corporation (“Capstone” or the “Company”) (NASDAQ: CGRN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Capstone and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether SolarEdge and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Brainstorm and certain of its officers and/or directors have engaged in securities fraud or other unlawful… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. – BCLI
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses in their Investment in Farfetch Limited of Class Action Lawsuit and Upcoming Deadline – FTCH
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and certain officers. The class action, filed in the United States District Court for the District of Maryland, Southern Division, and docketed under 23-cv-02857, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses in their Investment in Farfetch Limited of Class Action Lawsuit and Upcoming Deadline – FTCH
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 23-cv-21862, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK